Selected research
Industry Growth & Trends
Global Chemical Drug and Biologic Drug Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Chemical Drug and Biologic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Chemical Drug and Biologic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Chemical Drug and Biologic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chemical Drug and Biologic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Chemical Drug and Biologic Drug market include Takeda, Teva, Sanofi, Johnson & Johnson, Novartis, Novo Nordisk, Merck & Co., Roche and Eli Lilly & Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Chemical Drug and Biologic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Chemical Drug and Biologic Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chemical Drug and Biologic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chemical Drug and Biologic Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Chemical Drug and Biologic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Chemical Drug and Biologic Drug Market by Company
Takeda
Teva
Sanofi
Johnson & Johnson
Novartis
Novo Nordisk
Merck & Co.
Roche
Eli Lilly & Co.
Pfizer
GlaxoSmithKline
Biogen
Bayer
Bristol Myers Squibb
Amgen
AbbVie
AstraZeneca
Gilead Sciences
Boehringer Ingelheim
Astellas
Chemical Drug and Biologic Drug Segment by Type
Chemical Drug
Biologic Drug
Chemical Drug and Biologic Drug Segment by Application
Hospital
Retail Pharmacy
Other
Chemical Drug and Biologic Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemical Drug and Biologic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chemical Drug and Biologic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemical Drug and Biologic Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Chemical Drug and Biologic Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Drug
- Biologic Drug
Applications
- Hospital
- Retail Pharmacy
- Other
Companies covered
- Takeda
- Teva
- Sanofi
- Johnson & Johnson
- Novartis
- Novo Nordisk
- Merck & Co.
- Roche
- Eli Lilly & Co.
- Pfizer
- GlaxoSmithKline
- Biogen
- Bayer
- Bristol Myers Squibb
- Amgen
- AbbVie
- AstraZeneca
- Gilead Sciences
- Boehringer Ingelheim
- Astellas
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Chemical Drug and Biologic Drug Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Chemical Drug and Biologic Drug Market Size by Region (2021-2032)
- 1.4.1 Global Chemical Drug and Biologic Drug Market Size by Region (2021-2026)
- 1.4.2 Global Chemical Drug and Biologic Drug Market Size by Region (2027-2032)
- 1.5 Key Regions Chemical Drug and Biologic Drug Market Size (2021-2032)
- 1.5.1 North America Chemical Drug and Biologic Drug Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Chemical Drug and Biologic Drug Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Chemical Drug and Biologic Drug Market Size Growth Rate (2021-2032)
- 1.5.4 South America Chemical Drug and Biologic Drug Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Chemical Drug and Biologic Drug Market Size Growth Rate (2021-2032)
2 Chemical Drug and Biologic Drug Market by Type
- 2.1 Type Introduction
- 2.1.1 Chemical Drug
- 2.1.2 Biologic Drug
- 2.2 Global Chemical Drug and Biologic Drug Market Size by Type
- 2.2.1 Global Chemical Drug and Biologic Drug Market Size Overview by Type (2021-2032)
- 2.2.2 Global Chemical Drug and Biologic Drug Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Chemical Drug and Biologic Drug Market Size Forecasted by Type (2027-2032)
- 2.3 Global Chemical Drug and Biologic Drug Market Size by Regions
- 2.3.1 North America Chemical Drug and Biologic Drug Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Chemical Drug and Biologic Drug Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Chemical Drug and Biologic Drug Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Chemical Drug and Biologic Drug Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Chemical Drug and Biologic Drug Market Size Breakdown by Type (2021-2026)
3 Chemical Drug and Biologic Drug Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Retail Pharmacy
- 3.1.3 Other
- 3.2 Global Chemical Drug and Biologic Drug Market Size by Application
- 3.2.1 Global Chemical Drug and Biologic Drug Market Size Overview by Application (2021-2032)
- 3.2.2 Global Chemical Drug and Biologic Drug Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Chemical Drug and Biologic Drug Market Size Forecasted by Application (2027-2032)
- 3.3 Global Chemical Drug and Biologic Drug Market Size by Regions
- 3.3.1 North America Chemical Drug and Biologic Drug Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Chemical Drug and Biologic Drug Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Chemical Drug and Biologic Drug Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Chemical Drug and Biologic Drug Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Chemical Drug and Biologic Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Chemical Drug and Biologic Drug Industry Trends
- 4.2 Chemical Drug and Biologic Drug Industry Drivers
- 4.3 Chemical Drug and Biologic Drug Industry Opportunities and Challenges
- 4.4 Chemical Drug and Biologic Drug Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Chemical Drug and Biologic Drug Revenue (2021-2026)
- 5.2 Global Chemical Drug and Biologic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Chemical Drug and Biologic Drug Key Company Headquarters & Area Served
- 5.4 Global Chemical Drug and Biologic Drug Company, Product Type & Application
- 5.5 Global Chemical Drug and Biologic Drug Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Chemical Drug and Biologic Drug Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Chemical Drug and Biologic Drug Players Market Share by Revenue in 2025
- 5.6.3 2025 Chemical Drug and Biologic Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Takeda Chemical Drug and Biologic Drug Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Teva Chemical Drug and Biologic Drug Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sanofi Chemical Drug and Biologic Drug Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Johnson & Johnson
- 6.4.1 Johnson & Johnson Company Information
- 6.4.2 Johnson & Johnson Business Overview
- 6.4.3 Johnson & Johnson Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Johnson & Johnson Chemical Drug and Biologic Drug Product Portfolio
- 6.4.5 Johnson & Johnson Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Novartis Chemical Drug and Biologic Drug Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Novo Nordisk
- 6.6.1 Novo Nordisk Company Information
- 6.6.2 Novo Nordisk Business Overview
- 6.6.3 Novo Nordisk Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Novo Nordisk Chemical Drug and Biologic Drug Product Portfolio
- 6.6.5 Novo Nordisk Recent Developments
- 6.7 Merck & Co.
- 6.7.1 Merck & Co. Company Information
- 6.7.2 Merck & Co. Business Overview
- 6.7.3 Merck & Co. Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Merck & Co. Chemical Drug and Biologic Drug Product Portfolio
- 6.7.5 Merck & Co. Recent Developments
- 6.8 Roche
- 6.8.1 Roche Company Information
- 6.8.2 Roche Business Overview
- 6.8.3 Roche Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Roche Chemical Drug and Biologic Drug Product Portfolio
- 6.8.5 Roche Recent Developments
- 6.9 Eli Lilly & Co.
- 6.9.1 Eli Lilly & Co. Company Information
- 6.9.2 Eli Lilly & Co. Business Overview
- 6.9.3 Eli Lilly & Co. Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Eli Lilly & Co. Chemical Drug and Biologic Drug Product Portfolio
- 6.9.5 Eli Lilly & Co. Recent Developments
- 6.10 Pfizer
- 6.10.1 Pfizer Company Information
- 6.10.2 Pfizer Business Overview
- 6.10.3 Pfizer Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Pfizer Chemical Drug and Biologic Drug Product Portfolio
- 6.10.5 Pfizer Recent Developments
- 6.11 GlaxoSmithKline
- 6.11.1 GlaxoSmithKline Company Information
- 6.11.2 GlaxoSmithKline Business Overview
- 6.11.3 GlaxoSmithKline Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 GlaxoSmithKline Chemical Drug and Biologic Drug Product Portfolio
- 6.11.5 GlaxoSmithKline Recent Developments
- 6.12 Biogen
- 6.12.1 Biogen Company Information
- 6.12.2 Biogen Business Overview
- 6.12.3 Biogen Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Biogen Chemical Drug and Biologic Drug Product Portfolio
- 6.12.5 Biogen Recent Developments
- 6.13 Bayer
- 6.13.1 Bayer Company Information
- 6.13.2 Bayer Business Overview
- 6.13.3 Bayer Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Bayer Chemical Drug and Biologic Drug Product Portfolio
- 6.13.5 Bayer Recent Developments
- 6.14 Bristol Myers Squibb
- 6.14.1 Bristol Myers Squibb Company Information
- 6.14.2 Bristol Myers Squibb Business Overview
- 6.14.3 Bristol Myers Squibb Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Bristol Myers Squibb Chemical Drug and Biologic Drug Product Portfolio
- 6.14.5 Bristol Myers Squibb Recent Developments
- 6.15 Amgen
- 6.15.1 Amgen Company Information
- 6.15.2 Amgen Business Overview
- 6.15.3 Amgen Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Amgen Chemical Drug and Biologic Drug Product Portfolio
- 6.15.5 Amgen Recent Developments
- 6.16 AbbVie
- 6.16.1 AbbVie Company Information
- 6.16.2 AbbVie Business Overview
- 6.16.3 AbbVie Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 AbbVie Chemical Drug and Biologic Drug Product Portfolio
- 6.16.5 AbbVie Recent Developments
- 6.17 AstraZeneca
- 6.17.1 AstraZeneca Company Information
- 6.17.2 AstraZeneca Business Overview
- 6.17.3 AstraZeneca Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 AstraZeneca Chemical Drug and Biologic Drug Product Portfolio
- 6.17.5 AstraZeneca Recent Developments
- 6.18 Gilead Sciences
- 6.18.1 Gilead Sciences Company Information
- 6.18.2 Gilead Sciences Business Overview
- 6.18.3 Gilead Sciences Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Gilead Sciences Chemical Drug and Biologic Drug Product Portfolio
- 6.18.5 Gilead Sciences Recent Developments
- 6.19 Boehringer Ingelheim
- 6.19.1 Boehringer Ingelheim Company Information
- 6.19.2 Boehringer Ingelheim Business Overview
- 6.19.3 Boehringer Ingelheim Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Boehringer Ingelheim Chemical Drug and Biologic Drug Product Portfolio
- 6.19.5 Boehringer Ingelheim Recent Developments
- 6.20 Astellas
- 6.20.1 Astellas Company Information
- 6.20.2 Astellas Business Overview
- 6.20.3 Astellas Chemical Drug and Biologic Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Astellas Chemical Drug and Biologic Drug Product Portfolio
- 6.20.5 Astellas Recent Developments
7 North America
- 7.1 North America Chemical Drug and Biologic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 7.3 North America Chemical Drug and Biologic Drug Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Chemical Drug and Biologic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 8.3 Europe Chemical Drug and Biologic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Chemical Drug and Biologic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Chemical Drug and Biologic Drug Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Chemical Drug and Biologic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 10.3 South America Chemical Drug and Biologic Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Chemical Drug and Biologic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Chemical Drug and Biologic Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst